Evaluation of Budesonide/Formoterol SPIROMAX® Versus SYMBICORT® TURBOHALER®

Study Title
Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAXֲ® Inhalation Powder Versus SYMBICORTֲ® TURBOHALERֲ®
Teva Identifier
BFS-AS-306 | 2013-000081-11
ClinicalTrials.gov Identifier
NCT01803555
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Budesonide/Formoterol SPIROMAXֲ® | Drug: SYMBICORTֲ® TURBOHALERֲ®

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
06/01/2013 - 07/01/2014
Phase
Phase 3

Study Type

Interventional